Ophthotech Corp. said it was undertaking a strategic review of the business.
The company engaged Leerink Partners LLC as its financial adviser to assist in evaluating the company's strategic alternatives. "[T]he principal focus of this plan ... is to actively explore obtaining rights to additional products, product candidates and technologies to treat ophthalmic diseases, particularly those of the back of the eye."
As part of those efforts, Ophthotech appointed Glenn Sblendorio as its new president and Keith Westby as its new senior vice president and COO.
Sblendorio will continue to serve as the company's CFO. Westby was previously Ophthotech's senior vice president of development operations.